Overview

Vasopressor Prophylaxis After Spinal Anesthesia

Status:
Completed
Trial end date:
2018-12-10
Target enrollment:
Participant gender:
Summary
Norepinephrine has been recently introduced as a prophylactic vasopressor during Cesarean delivery with promising results ; However, the optimum dose for efficient prophylaxis with the least side effects is not known. In this study, we will compare three doses (0.05, 0.1, 0.15 mcg/Kg/min) of norepinephrine for prophylaxis against Post-Spinal hypotension during cesarean delivery.
Phase:
Phase 4
Details
Lead Sponsor:
Cairo University
Treatments:
Anesthetics
Bupivacaine
Norepinephrine